We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
Cap. Flow
-$6.04M
Cap. Flow %
-0.54%
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$15M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$10.6M
3
JXN icon
Jackson Financial
JXN
+$10.4M
4
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$9.86M
5
TVTX icon
Travere Therapeutics
TVTX
+$6.57M

Top Sells

Rank Stock Value
1
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$32.2M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$12.8M
3
BBWI icon
Bath & Body Works
BBWI
+$11M
4
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$9.94M
5
FWONA icon
Liberty Media Series A
FWONA
+$9.64M

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 10.97%
3 Technology 7.15%
4 Communication Services 3.95%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAMI
26
Acadian Asset Management
AAMI
$2.88B
$6.43M 0.58%
+246,008
New +$6.34M
CNNE icon
27
Cannae Holdings
CNNE
$647M
$6.34M 0.57%
+203,670
New +$6.56M
GRFS
28
Grifois
GRFS
$5.16B
$6.11M 0.55%
418,110
– –
PCG icon
29
PG&E
PCG
$47.8B
$6.06M 0.54%
631,163
– –
LTCHW
30
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
$5.96M 0.53%
+529,048
New +$1.97M
RITM icon
31
Rithm Capital
RITM
$5.09B
$5.92M 0.53%
538,089
-275,000
-34% -$2.82M
SDAWW
32
SunCar Technology Group Warrant
SDAWW
$16.4M
$5.91M 0.53%
595,917
-75,413
-11% -$23.2K
ALIT.WS
33
DELISTED
Alight Inc Warrants
ALIT.WS
$5.9M 0.53%
+513,940
New +$1.28M
RMCOW icon
34
Royalty Management Holding Warrant
RMCOW
$1.49M
$5.85M 0.52%
592,501
-4,944
-0.8% -$3.16K
XONE
35
DELISTED
The ExOne Company
XONE
$5.48M 0.49%
+234,257
New +$4.91M
TRIL
36
DELISTED
Trillium Therapeutics Inc.
TRIL
$5.44M 0.49%
+310,000
New +$3.62M
RCI icon
37
Rogers Communications
RCI
$17.7B
$5.39M 0.48%
+115,403
New +$5.81M
CND.WS
38
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$5.33M 0.48%
+528,708
New +$983K
LAUR icon
39
Laureate Education
LAUR
$5.18B
$5.25M 0.47%
+309,281
New +$4.86M
MMVWW
40
DELISTED
MultiMetaVerse Holdings Limited Warrant
MMVWW
$5.21M 0.47%
522,275
+399,758
+326% +$210K
SEEL
41
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$5.14M 0.46%
556
– –
FLOW
42
DELISTED
SPX FLOW, Inc.
FLOW
$5.08M 0.45%
+69,455
New +$5.28M
DFNSW
43
T3 Defense Inc Warrants
DFNSW
$397K
$5.07M 0.45%
500,000
+364,484
+269% +$167K
ONMDW icon
44
OneMedNet Corp Warrant
ONMDW
$873K
$5.03M 0.45%
+500,000
New +$247K
ACBAW
45
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$5.03M 0.45%
500,000
+208,197
+71% +$116K
ICUCW
46
SeaStar Medical Holding Corp Warrant
ICUCW
$413K
$5.02M 0.45%
500,000
– –
BENEW
47
DELISTED
Benessere Capital Acquisition Corp. Warrant
BENEW
$5.02M 0.45%
500,000
– –
MAQCW
48
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$5.01M 0.45%
+500,050
New +$275K
SCLXW icon
49
Scilex Holding Co Warrant
SCLXW
$2.55M
$5M 0.45%
500,000
– –
GLSPW
50
DELISTED
Global SPAC Partners Co. Warrants
GLSPW
$4.99M 0.45%
500,000
– –
1
2
3 4 5

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Mangrove Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.

  • Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
  • Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
  • Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
  • Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
  • Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.